PDI, Inc. (PDII) Director Frank J. Ryan to Retire from Board  
5/1/2012 11:46:49 AM

PARSIPPANY, N.J., May 1, 2012 /PRNewswire/ -- PDI, Inc. (Nasdaq: PDII) today announced that Frank J. Ryan will be retiring from PDI's Board of Directors, effective May 28, 2012, after almost 10 years of service.

"Frank has been a valued and integral member of our Board for the past decade, providing steady oversight and insightful counsel as PDI underwent a strategic transformation to become the strong company it is today," said Nancy Lurker, Chief Executive Officer of PDI. "We are deeply grateful to Frank for his years of service and important contributions, and all of us at PDI want to extend our very best wishes to him."

Ryan joined PDI's Board in November 2002 after a 38-year career with Johnson & Johnson. He retired from J&J in 2001 as company group chairman with responsibility for worldwide Ethicon franchises and Johnson & Johnson Canada. In addition, Ryan was a member of the Medical Devices and Diagnostics Operating Group and Leader for the Group in Process Excellence (Six Sigma) and IT. He had earlier served as J&J's worldwide president of Chicopee, president of Johnson and Johnson Hospital Services Co., and president of Ethicon, Inc. He was a director of Digene Corporation from June 2005 until its acquisition by Qiagen N.V. in July 2007.

About PDI, Inc.
PDI is a leading health care commercialization company providing superior insight-driven, integrated multi-channel message delivery to established and emerging health care companies. The company is dedicated to enhancing engagement with health care practitioners and optimizing commercial investments for its clients by providing strategic flexibility, full product commercialization services, innovative multi-channel promotional solutions, and sales and marketing expertise. For more information, please visit the company's website at